- Aptar Digital Health will be the preferred digital partner for Enable Injections to develop a companion digital solution for the enFuse on-body delivery system.
- Planned features include onboarding and training modules, injection guidance, treatment data logging, patient-reported outcomes and symptom tracking.
- The solution is modular and scalable to support use cases from clinical trials through commercialization and to integrate with program-specific needs.
- Device-generated and patient-reported data will be captured remotely, stored securely and delivered via analytics dashboards to inform clinical development, launch readiness and real-world use.
Partnership
Aptar Digital Health is named Enable Injections' preferred digital partner to develop a companion digital solution for the enFuse On-Body Delivery System.
Companion features
Planned features include onboarding and training modules, injection guidance, treatment data recording, patient-reported outcomes and symptom tracking to support adherence and caregiver use.
Architecture and use cases
The solution is built on a flexible, scalable architecture to deploy alongside the enFuse device and to support use cases from clinical trials through commercialization with modular, program-specific integration.
Data and analytics
Device-generated and patient-reported data will be captured remotely, stored securely and made available via analytics dashboards to inform clinical development, launch readiness and real-world evidence generation.
